Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982639priorityCriticalpatent/ECSP982639A/en
Publication of ECSP982639ApublicationCriticalpatent/ECSP982639A/en
Un método para tratar o prevenir enfermedades inflamatorias e inmunes mediadas por las células, por administración de ciertas moléculas pequeñas nuevas y conocidas. Ejemplos de los nuevos compuestos son los de las fórmulas estructurales siguientesA method of treating or preventing inflammatory and immune diseases mediated by cells, by administration of certain new and known small molecules. Examples of the new compounds are those of the following structural formulas
ECSP9826391998-08-251998-08-25
SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE
ECSP982639A
(en)
DERIVATIVES OF 5-CARBAMIMIDOI-2-METILSULFANILTIOFEN-3-SULFONIL AS CONJUGATED INHIBITORS OF THE COMPLEMENT CASCADE AND ITS USE IN THE TREATMENT OF DISEASES.